Type 2 Diabetes

Physical Activity and Type 2 Diabetes: When and How Much?

Both the timing and amount of physical activity are important in risk reduction and management of type 2 diabetes.

SUSTAIN-6: Cardiovascular Safety of Semaglutide in Type 2 Diabetes

Researchers found the cardiovascular safety of semaglutide was noninferior to placebo in high-risk patients with type 2 diabetes.

How Do We Use Technology for Diabetes Management?

Edward C. Chao, DO, highlights important considerations for developing technology for diabetes management.

Implementing Diabetes Self-Management Education in Type 2 Diabetes

Joan K. Bardsley, MBA, RN, CDE, describes a joint position statement regarding implementation of diabetes self-management education.

Role of the Gut Microbiome in Diabetes

Research shows that further understanding of the gut microbiome may improve diagnosis, prevention, and treatment of the disease earlier in life.

Preventing Diabetes and Complications: What Are the Challenges?

A change in how patients and physicians view diabetes may is necessary for preventing the disease and its complications.

LEADER: Liraglutide Decreased Rate of CV Events in High-Risk Type 2 Diabetes

Compared with placebo, liraglutide decreased the rate of cardiovascular events in high-risk patients with diabetes.

SGLT2 Inhibitors: A Class Effect?

Data on cardiovascular benefits as well as adverse effects have thrust this class of diabetes drugs into the spotlight.

Physical Activity Deficiency: A New Risk Factor for Type 2 Diabetes?

Sedentary behaviors may boost risk for type 2 diabetes by 22% and risk for metabolic syndrome by 39%.

AACE Issues Consensus Statement on Outpatient Glucose Monitoring in Diabetes

The new consensus statement reflects the advances made in glucose monitoring technology and offers guidance for clinicians.

AACE/ACE Updates Algorithm for Type 2 Diabetes Management

The American Association of Clinical Endocrinologists' updated algorithm for type 2 diabetes management addresses lifestyle modifications and obesity treatments.

Video

Latest Headlines

Type 2 Diabetes Therapy Intensification: Part II: GLP-1 Agonist Adverse Effects and Fixed-Ratio Combinations

Type 2 Diabetes Therapy Intensification: Part II: GLP-1 Agonist Adverse Effects and Fixed-Ratio Combinations

When basal insulin no longer provides adequate glucose control in type 2 diabetes, a rapid-acting insulin or a glucagon-like peptide-1 receptor agonist may be used to intensify therapy.

Type 2 Diabetes Therapy Intensification: Part I: Insulin vs GLP-1 Agonists

Type 2 Diabetes Therapy Intensification: Part I: Insulin vs GLP-1 Agonists

When basal insulin no longer provides adequate glucose control in type 2 diabetes, a rapid-acting insulin or a glucagon-like peptide-1 receptor agonist may be used to intensify therapy.

Is Normal Basal Bone Metabolism Vitamin D-Dependent in Postmenopausal Women With T2D?

Is Normal Basal Bone Metabolism Vitamin D-Dependent in Postmenopausal Women With T2D?

Findings in postmenopausal women with T2DM; correlations prominent in those with higher 25(OH)D

Weekly GLP-1 Analog Improves Glycemic Control vs Glargine in T2D Inadequately Controlled on Metformin

Weekly GLP-1 Analog Improves Glycemic Control vs Glargine in T2D Inadequately Controlled on Metformin

A phase 3a trial evaluates whether the novel glucagon-like peptide-1 analog semaglutide substantially improved glycemic control compared with insulin glargine in patients with type 2 diabetes inadequately controlled with metformin.

Can Compression Socks Be Safely Used in Diabetics With Lower Extremity Edema?

Can Compression Socks Be Safely Used in Diabetics With Lower Extremity Edema?

A randomized controlled trial assessed whether mild lower extremity compression can be safely used in patients with diabetes and concurrent lower extremity edema.

Hypertension Family History May Accelerate Type 2 Diabetes Onset

Hypertension Family History May Accelerate Type 2 Diabetes Onset

A retrospective cohort study evaluated whether having a family history of hypertension accelerates onset of type 2 diabetes.

Urine Metabolomic Profiling: 5-HT Metabolism Contributes to DM Pathogenesis

Urine Metabolomic Profiling: 5-HT Metabolism Contributes to DM Pathogenesis

Derangements in serotonin metabolism and mitochondrial dysfunction may be inhibiting insulin secretion.

Daily Insulin Injection Vs Continuous Subcutaneous Infusion in Type 2 Diabetes

Daily Insulin Injection Vs Continuous Subcutaneous Infusion in Type 2 Diabetes

A broad range of patients with type 2 diabetes may benefit from continuous subcutaneous insulin infusion.

Inpatient Virtual Glucose Management Service Decreases Hyperglycemia, Hypoglycemia

Inpatient Virtual Glucose Management Service Decreases Hyperglycemia, Hypoglycemia

A study sought to determine if a virtual glucose management service can result in improved inpatient glycemic control.

Does Fiber Source Affect Plasma Glucose and Insulin in Type 2 Diabetes?

Does Fiber Source Affect Plasma Glucose and Insulin in Type 2 Diabetes?

Postprandial plasma glucose and insulin measurements were similar, regardless of fiber source.

Sign Up for Free e-Newsletters